ArticleDiscover oncology2025

Hsa-circVIM regulates breast cancer tumor progression and tamoxifen sensitivity by sponging miR-1294 in hormone receptor-positive breast cancer cells.

Ying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.